Generic Name and Formulations:
Chlophedianol HCl 12.5mg, pseudoephedrine HCl 30mg; per 5mL; syrup; alcohol-, dye-, gluten-, sugar-free; grape flavor.
Centrix Pharmaceutical, Inc.
Indications for CLOFERA:
Nonproductive cough, nasal congestion.
10mL every 6–8 hours; max 4 doses/24 hours.
<6yrs: not recommended. 6–11yrs: 5mL every 6–8 hours; max 4 doses/24 hours.
During or within 14 days of MAOIs.
Cardiovascular disease. Hypertension. Thyroid disease. Diabetes. GI or GU obstruction. Asthma. Lower respiratory disorders. Pregnancy. Nursing mothers.
Antitussive + sympathomimetic.
See Contraindications. Hypertensive crisis with MAOIs. β-blockers may increase pressor effects of sympathomimetics. Antihypertensives antagonized.
Nervousness, dizziness, insomnia.
Endocrinology Advisor Articles
- Cushing Syndrome Results in Poor Quality of Life Even After Remission
- DPP-4 Inhibitors and Incidence of Rheumatoid Arthritis in Type 2 Diabetes
- Cost-Benefit Analysis of Insulin Analogs in Type 2 Diabetes
- Nonfunctioning Adrenal Incidentaloma Associated With Metabolic Syndrome
- Low Predictive Power of Biomarkers for Estimated Glomerular Filtration Rate Decline
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Link Between Gestational Diabetes and Risk for CVD and Diabetes in Hispanic/Latina Population
- Clinical Characteristics Altering Risks and Benefits of Sulfonylureas and Thiazolidinedione Therapy in T2D
- 6 Factors Related to Inclusion in Health Care Workplace Identified
- Weight Gain After Quitting Smoking May Increase Risk for T2D